Filing Details

Accession Number:
0001209191-21-033989
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-19 16:08:20
Reporting Period:
2021-05-17
Accepted Time:
2021-05-19 16:08:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406338 Amit Sachdev C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Chief Patient Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-17 8 $215.59 40,170 No 4 S Direct
Common Stock Disposition 2021-05-17 32 $216.40 40,138 No 4 S Direct
Common Stock Disposition 2021-05-17 5 $217.27 40,133 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 882 Indirect 401(k)
Common Stock 7,368 Indirect Held in Trust
Footnotes
  1. Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $215.59 (range $214.94 to $215.93).
  3. Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $216.40 (range $215.95 to $216.91).
  5. Open market sales reported on this line occurred at a weighted average price of $217.27 (range $217.05 to $217.46).